With the robust demand for personalized medicines and the growing adoption of digital technology, the precision medicine ...

Additional data from CheckMate 274 showed that adjuvant nivolumab benefits patients with muscle-invasive bladder cancer with ...

Q4 2024 Earnings Call Transcript February 20, 2025 Prothena Corporation plc misses on earnings expectations. Reported EPS is ...

The OCEANIC-AF trial has raised concerns about factor XI inhibitors. Should physicians still bet on this class of ...

Sandra Leung began her legal career prosecuting homicides, a formative experience that she once said taught her "to make ...

Merck’s Keytruda may be the most talked about drug facing loss of exclusivity but it’s far from the only one, as several of ...

and discontinuation rates were 14.6% and 6.7%, respectively. The results nevertheless make Opdualag an alternative to Opdivo plus Yervoy (ipilimumab) – BMS' notoriously hard to tolerate CTLA4 ...

Li-S Energy has reported it is moving strongly towards commercial partnerships, after major breakthroughs and industry wins.

Citi's 2025 Global Industrial Tech and Mobility Conference February 20, 2025 1:50 PM ET. Company Participants. Dave Gitlin - Chief Executive ...

Ciltacabtagene autoleucel improved minimal residual disease negativity and sustained responses vs standard care in ...

Traditional data centers often operate with significant power headroom to handle peak loads, leading to energy waste during normal operations.

Helen Torley; President, Chief Executive Officer, Director; Halozyme Therapeutics Inc Nicole Labrosse; Chief Financial Officer, Senior Vice President; Halozyme Therapeutics Inc Good afternoon. My name ...